Document is current
Any future updates will be listed below
-
Authors
Ghirelli, Alma
Spinelli, Edoardo Gioele
Canu, Elisa
Basaia, Silvia
Castelnovo, Veronica
Cecchetti, Giordano
Sibilla, Elisa
Domi, Teuta
Magnani, Giuseppe
Caso, Francesca
Caroppo, Paola
Prioni, Sara
Villa, Cristina
Rossi, Giacomina
Tremolizzo, Lucio
Appollonio, Ildebrando
Verde, Federico
Ticozzi, Nicola
Silani, Vincenzo
Filippi, Massimo
Agosta, Federica http://orcid.org/0000-0003-3121-4979
-
Funding
Funding for this research was provided by:
H2020 European Research Council (StG-2016_714388_NeuroTRACK)
Fondation pour la Recherche sur Alzheimer
Ministero della Salute (Next Generation EU)
- License Information
-
More Information
Article History
Received: 21 December 2023
Revised: 19 February 2024
Accepted: 18 March 2024
First Online: 10 April 2024
Declarations
:
: A. Ghirelli and E.G. Spinelli has nothing to disclose. E. Canu has received research supports from the Italian Ministry of Health. S. Basaia has received research supports from the Italian Ministry of Health. V. Castelnovo, G. Cecchetti, E. Sibilla, T. Domi, G. Magnani, F. Caso, P. Caroppo, S. Prioni, C. Villa, G. Rossi, L. Tremolizzo, I. Apollonio, F. Verde, N. Ticozzi, and V. Silani has nothing to disclose. M. Filippi is Editor-in-Chief of the Journal of Neurology; Associate Editor of Human Brain Mapping, Neurological Sciences, and Radiology; received compensation for consulting services from Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi, speaking activities from Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA, participation in Advisory Boards for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda, scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol-Myers Squibb, Lilly, Novartis, Sanofi-Genzyme; he receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. F. Agosta is Associate Editor of NeuroImage: Clinical; has received speaker honoraria from Biogen Idec, Italfarmaco, Roche, Zambon and Eli Lilly; and receives or has received research supports from the Italian Ministry of Health, the Italian Ministry of University and Research, AriSLA (Fondazione Italiana di Ricerca per la SLA), the European Research Council, the EU Joint Programme—Neurodegenerative Disease Research (JPND), and Foundation Research on Alzheimer Disease (France).
: The local ethical standards committee on human experimentation approved the study protocol and all participants provided written informed consent.
